378
Participants
Start Date
November 11, 2019
Primary Completion Date
October 31, 2026
Study Completion Date
December 31, 2026
DF1001
Immunotherapy agent targeting NK cells.
Nivolumab
Anti-PD-1 immunotherapy agent
Nab paclitaxel
A chemotherapy treatment combining paclitaxel with albumin
Sacituzumab Govitecan-hziy
A Trop-2 (Tumor-associated calcium signal transducer 2) directed antibody and topoisomerase inhibitor drug conjugate
RECRUITING
Rigshospitalet, Copenhagen
RECRUITING
Herlev og Gentofte Hospital, Herlev
RECRUITING
Domaine Universitaire du Sart Tilman; CHU de Liege, Liège
RECRUITING
Grand Hopital de Charleroi, Charleroi
RECRUITING
Centre Hospitalier de l'Ardenne, Arlon
ACTIVE_NOT_RECRUITING
Icahn School of Medicine: Tisch Cancer Institute at Mount Sinai Medical Center, New York
RECRUITING
Montefiore Einstein Center for Cancer Care, The Bronx
RECRUITING
Institut Paoli Calmettes, Marseille
WITHDRAWN
University of Pennsylvania, Abramson Cancer Center, Philadelphia
RECRUITING
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
RECRUITING
Institut Claudius Regaud, Toulouse
RECRUITING
Groupe Hospitalier Saint Andre, Bordeaux
RECRUITING
Vanderbilt-Ingram Cancer Center, Nashville
RECRUITING
The Ohio State University, Columbus
RECRUITING
University Hospitals Cleveland Medical Center, Cleveland
RECRUITING
ICO - Site Rene Gauducheau, Saint-Herblain
WITHDRAWN
University of Michigan, Ann Arbor
WITHDRAWN
Henry Ford Health System, Detroit
RECRUITING
University of Wisconsin, Madison
RECRUITING
Centre Oscar Lambret, Lille
ACTIVE_NOT_RECRUITING
University of Kansas Medical Center Research Institute, Inc., Westwood
RECRUITING
Centre Leon Berard, Lyon
RECRUITING
Louisiana State University, New Orleans
RECRUITING
Institut Curie, Paris
RECRUITING
MD Anderson Cancer Center, Houston
RECRUITING
University of Southern California, Los Angeles
RECRUITING
Sharp Healthcare, San Diego
RECRUITING
University of California Irvine Medical Center, Irvine
RECRUITING
University of California San Francisco, San Francisco
ACTIVE_NOT_RECRUITING
Multicare Health System Tacoma General Hospital, Tacoma
RECRUITING
Rhode Island Hospital, Providence
RECRUITING
Centre Georges-Francois Leclerc, Dijon
RECRUITING
Institut Regional du Cancer de Montepelier, Montpellier
RECRUITING
Groupe Hospitalier Pitie Salpetriere, Paris
RECRUITING
CHU de Rennes Hopital Pontechaillou, Rennes
RECRUITING
Inje University Haeundae Paik Hospital, Busan
RECRUITING
Kosin University Gospel Hospital, Busan
RECRUITING
National Cancer Center, Goyang-si
RECRUITING
Ajou University Hospital, Gyeonggi-do
RECRUITING
CHA Bundang Medical Center, CHA University, Gyeonggi-do
RECRUITING
Seoul National University Bundang Hospital, Seongnam
RECRUITING
Asan Medical Center, Seoul
RECRUITING
Korea University Guro Hospital, Seoul
RECRUITING
Seoul National University Hospital, Seoul
RECRUITING
Severance Hospital, Seoul
RECRUITING
The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul
ACTIVE_NOT_RECRUITING
Amsterdam University Medical Center, Amsterdam
ACTIVE_NOT_RECRUITING
Universitair Medisch Centrum Groningen, Groningen
ACTIVE_NOT_RECRUITING
Maasticht University Medical Center, Maastricht
ACTIVE_NOT_RECRUITING
Radboud University Nijmegen, Nijmegen
ACTIVE_NOT_RECRUITING
Erasmus University Medical Center, Rotterdam
ACTIVE_NOT_RECRUITING
UMC Utrecht, Utrecht
Lead Sponsor
Dragonfly Therapeutics
INDUSTRY